Meningococcal group B vaccine (Pfizer)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal group B vaccine (Pfizer)
Drug Alias Namemeningococcal group b vaccine (recombinant, adsorbed)B็พค่„‘่†œ็‚Ž็ƒ่Œ็–ซ่‹—meningococcal B rLP2086 vaccine้‡็ป„B็พค่„‘่†œ็‚Ž็ƒ่ŒxiTrumenba +[9]ย 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisMeningococcal InfectionsMeningitis, Meningococcal +[4]ย 
Global Approved IndicationsMeningitisMeningococcal InfectionsMeningitis, Meningococcal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/10/29
Country/TerritoryCzechiaCanadaUnited States +[10]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Europe Ma Eeig
Inactive CompaniesWyeth LlcPfizer Inc
Active IndicationsMeningitisMeningococcal InfectionsMeningitis, Meningococcal
Inactive IndicationsInfluenza B virus infection

Other Information

ATC CodeJ07AH09
Related LinksN/A